Guidelines for management of intra-abdominal infections.

Community-Acquired Infections/diagnosis/therapy; Cross Infection/diagnosis/therapy; Humans; Intraabdominal Infections/diagnosis/therapy; Postoperative Complications/diagnosis/therapy

Abstract :

[en] Intra-abdominal infections are one of the most common gastrointestinal emergencies and a leading cause of septic shock. A consensus conference on the management of community-acquired peritonitis was published in 2000. A new consensus as well as new guidelines for less common situations such as peritonitis in paediatrics and healthcare-associated infections had become necessary. The objectives of these Clinical Practice Guidelines (CPGs) were therefore to define the medical and surgical management of community-acquired intra-abdominal infections, define the specificities of intra-abdominal infections in children and describe the management of healthcare-associated infections. The literature review was divided into six main themes: diagnostic approach, infection source control, microbiological data, paediatric specificities, medical treatment of peritonitis, and management of complications. The GRADE((R)) methodology was applied to determine the level of evidence and the strength of recommendations. After summarising the work of the experts and application of the GRADE((R)) method, 62 recommendations were formally defined by the organisation committee. Recommendations were then submitted to and amended by a review committee. After 2 rounds of Delphi scoring and various amendments, a strong agreement was obtained for 44 (100%) recommendations. The CPGs for peritonitis are therefore based on a consensus between the various disciplines involved in the management of these patients concerning a number of themes such as: diagnostic strategy and the place of imaging; time to management; the place of microbiological specimens; targets of empirical anti-infective therapy; duration of anti-infective therapy. The CPGs also specified the value and the place of certain practices such as: the place of laparoscopy; the indications for image-guided percutaneous drainage; indications for the treatment of enterococci and fungi. The CPGs also confirmed the futility of certain practices such as: the use of diagnostic biomarkers; systematic relaparotomies; prolonged anti-infective therapy, especially in children.

Disciplines :

Anesthesia & intensive care

Author, co-author :

Montravers, Philippe

Dupont, Herve

Leone, Marc

Constantin, Jean-Michel

Mertes, Paul-Michel

Laterre, Pierre-Francois

Misset, Benoît ; Centre Hospitalier Universitaire de Liège - CHU > Service de Soins Intensifs

Bru, Jean-Pierre

Gauzit, Remy

Sotto, Albert

More authors (3 more)

Language :

English

Title :

Guidelines for management of intra-abdominal infections.

Publication date :

2015

Journal title :

Anaesthesia, Critical Care and Pain Medicine

eISSN :

2352-5568

Volume :

Issue :

Pages :

117-30

Peer reviewed :

Peer Reviewed verified by ORBi

Commentary :

Available on ORBi :

since 21 February 2020

Statistics

Number of views

110 (1 by ULiège)

Number of downloads

1 (0 by ULiège)

More statistics

Scopus citations^®

112

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

137

Bibliography

[1] McGillicuddy, E.A., Schuster, K.M., Davis, K.A., Longo, W.E., Factors predicting morbidity and mortality in emergency colorectal procedures in elderly patients. Arch Surg 144 (2009), 1157–1162.
[2] Pisanu, A., Reccia, I., Deplano, D., Porru, F., Uccheddu, A., Factors predicting in-hospital mortality of patients with diffuse peritonitis from perforated colonic diverticulitis. Ann Ital Chir 83 (2012), 319–324.
[3] Sotto, A., Lefrant, J.Y., Fabbro-Peray, P., Muller, L., Tafuri, J., Navarro, F., et al. Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis. J Antimicrob Chemother 50 (2002), 569–576.
[4] Theunissen, C., Cherifi, S., Karmali, R., Management and outcome of high-risk peritonitis: a retrospective survey 2005–2009. Int J Infect Dis 15 (2011), e769–e773.
[5] Torer, N., Yorganci, K., Elker, D., Sayek, I., Prognostic factors of the mortality of postoperative intraabdominal infections. Infection 38 (2010), 255–260.
[6] Kang, C.I., Chung, D.R., Ko, K.S., Peck, K.R., Song, J.H., Risk factors for mortality and impact of broad-spectrum cephalosporin resistance on outcome in bacteraemic intra-abdominal infections caused by Gram-negative bacilli. Scand J Infect Dis 43 (2011), 202–208.
[7] Montravers, P., Lepape, A., Dubreuil, L., Gauzit, R., Pean, Y., Benchimol, D., et al. Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study. J Antimicrob Chemother 63 (2009), 785–794.
[8] Riche, F.C., Dray, X., Laisne, M.J., Mateo, J., Raskine, L., Sanson-Le Pors, M.J., et al. Factors associated with septic shock and mortality in generalized peritonitis: comparison between community-acquired and postoperative peritonitis. Crit Care, 13, 2009, R99.
[9] Société française d'anesthésie et de réanimation, Prise en charge hémodynamique du sepsis sévère (nouveau-né exclus). 2005 p Conférence de consensus commune organisée par la Sfar, 2005 http://www.sfar.org/t/spip.php?article289.
[10] Bertleff, M.J., Lange, J.F., Laparoscopic correction of perforated peptic ulcer: first choice?. A review of literature. Surg Endosc 24 (2010), 1231–1239.
[11] Sauerland, S., Agresta, F., Bergamaschi, R., Borzellino, G., Budzynski, A., Champault, G., et al. Laparoscopy for abdominal emergencies: evidence-based guidelines of the European Association for Endoscopic Surgery. Surg Endosc 20 (2006), 14–29.
[12] Bretagnol, F., Pautrat, K., Mor, C., Benchellal, Z., Huten, N., de Calan, L., Emergency laparoscopic management of perforated sigmoid diverticulitis: a promising alternative to more radical procedures. J Am Coll Surg 206:4 (2008), 654–657.
[13] Mazza, D., Chio, F., Khoury-Helou, A., [Conservative laparoscopic treatment of diverticular peritonitis]. J Chir 146 (2009), 265–269.
[14] Myers, E., Hurley, M., O'Sullivan, G.C., Kavanagh, D., Wilson, I., Winter, D.C., Laparoscopic peritoneal lavage for generalized peritonitis due to perforated diverticulitis. Br J Surg 95 (2008), 97–101.
[15] Taylor, C.J., Layani, L., Ghusn, M.A., White, S.I., Perforated diverticulitis managed by laparoscopic lavage. ANZ J Surg 76 (2006), 962–965.
[16] Akinci, D., Akhan, O., Ozmen, M.N., Karabulut, N., Ozkan, O., Cil, B.E., et al. Percutaneous drainage of 300 intraperitoneal abscesses with long-term follow-up. Cardiovasc Intervent Radiol 28 (2005), 744–750.
[17] Cinat, M.E., Wilson, S.E., Din, A.M., Determinants for successful percutaneous image-guided drainage of intra-abdominal abscess. Arch Surg 137 (2002), 845–849.
[18] Politano, A.D., Hranjec, T., Rosenberger, L.H., Sawyer, R.G., Tache Leon, C.A., Differences in morbidity and mortality with percutaneous versus open surgical drainage of postoperative intra-abdominal infections: a review of 686 cases. Am Surg 77 (2011), 862–867.
[19] Gervais, D.A., Ho, C.H., O'Neill, M.J., Arellano, R.S., Hahn, P.F., Mueller, P.R., Recurrent abdominal and pelvic abscesses: incidence, results of repeated percutaneous drainage, and underlying causes in 956 drainages. AJR Am J Roentgenol 182 (2004), 463–466.
[20] Kim, Y.J., Han, J.K., Lee, J.M., Kim, S.H., Lee, K.H., Park, S.H., et al. Percutaneous drainage of postoperative abdominal abscess with limited accessibility: preexisting surgical drains as alternative access route. Radiology 239 (2006), 591–598.
[21] Lamme, B., Boermeester, M.A., Belt, E.J., van Till, J.W., Gouma, D.J., Obertop, H., Mortality and morbidity of planned relaparotomy versus relaparotomy on demand for secondary peritonitis. Br J Surg 91 (2004), 1046–1054.
[22] Mulier, S., Penninckx, F., Verwaest, C., Filez, L., Aerts, R., Fieuws, S., et al. Factors affecting mortality in generalized postoperative peritonitis: multivariate analysis in 96 patients. World J Surg 27 (2003), 379–384.
[23] Penninckx, F., Kerremans, R., Filez, L., Ferdinande, P., Schets, M., Lauwers, P., Planned relaparotomies for advanced, established peritonitis from colonic origin. Acta Chir Belg 90 (1990), 269–274.
[24] Rakic, M., Popovic, D., Rakic, M., Druzijanic, N., Lojpur, M., Hall, B.A., et al. Comparison of on-demand vs. planned relaparotomy for treatment of severe intra-abdominal infections. Croat Med J 46 (2005), 957–963.
[25] van Ruler, O., Mahler, C.W., Boer, K.R., Reuland, E.A., Gooszen, H.G., Opmeer, B.C., et al. Comparison of on-demand vs. planned relaparotomy strategy in patients with severe peritonitis: a randomized trial. JAMA 298 (2007), 865–872.
[26] Seguin, P., Laviolle, B., Chanavaz, C., Donnio, P.Y., Gautier-Lerestif, A.L., Campion, J.P., et al. Factors associated with multidrug-resistant bacteria in secondary peritonitis: impact on antibiotic therapy. Clin Microbiol Infect 12 (2006), 980–985.
[27] Gauzit, R., Pean, Y., Barth, X., Mistretta, F., Lalaude, O., Epidemiology, management, and prognosis of secondary non-postoperative peritonitis: a French prospective observational multicenter study. Surg Infect 10 (2009), 119–127.
[28] Hawser, S., Hoban, D., Bouchillon, S., Badal, R., Carmeli, Y., Hawkey, P., Antimicrobial susceptibility of intra-abdominal gram-negative bacilli from Europe: SMART Europe 2008. Eur J Clin Microbiol Infect Dis 30 (2011), 173–179.
[29] Dupont, H., Paugam-Burtz, C., Muller-Serieys, C., Fierobe, L., Chosidow, D., Marmuse, J.P., et al. Predictive factors of mortality due to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients. Arch Surg 137 (2002), 1341–1346 [discussion 1347].
[30] Krobot, K., Yin, D., Zhang, Q., Sen, S., Altendorf-Hofmann, A., Scheele, J., et al. Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery. Eur J Clin Microbiol Infect Dis 23 (2004), 682–687.
[31] Sturkenboom, M.C., Goettsch, W.G., Picelli, G., in't Veld, B., Yin, D.D., de Jong, R.B., et al. Inappropriate initial treatment of secondary intra-abdominal infections leads to increased risk of clinical failure and costs. Br J Clin Pharmacol 60 (2005), 438–443.
[32] Hsueh, P.R., Badal, R.E., Hawser, S.P., Hoban, D.J., Bouchillon, S.K., Ni, Y., et al. Epidemiology and antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2008 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). Int J Antimicrob Agents 36 (2010), 408–414.
[33] European Centre for Disease Prevention and Control. Antimicrobial resistance interactive database (EARS-Net). http://www.ecdc.europa.eu/en/healthtopics/antimicrobial_resistance/database/Pages/database.aspx; accessed September 20th 2014.
[34] Lee, S.C., Fung, C.P., Chen, H.Y., Li, C.T., Jwo, S.C., Hung, Y.B., et al. Candida peritonitis due to peptic ulcer perforation: incidence rate, risk factors, prognosis and susceptibility to fluconazole and amphotericin B. Diagn Microbiol Infect Dis 44 (2002), 23–27.
[35] Montravers, P., Dupont, H., Gauzit, R., Veber, B., Auboyer, C., Blin, P., et al. Candida as a risk factor for mortality in peritonitis. Crit Care Med 34 (2006), 646–652.
[36] Shan, Y.S., Hsu, H.P., Hsieh, Y.H., Sy, E.D., Lee, J.C., Lin, P.W., Significance of intraoperative peritoneal culture of fungus in perforated peptic ulcer. Br J Surg 90 (2003), 1215–1219.
[37] Dupont, H., Bourichon, A., Paugam-Burtz, C., Mantz, J., Desmonts, J.M., Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis?. Crit Care Med 31 (2003), 752–757.
[38] Cercenado, E., Torroba, L., Canton, R., Martinez-Martinez, L., Chaves, F., Garcia-Rodriguez, J.A., et al. Multicenter study evaluating the role of enterococci in secondary bacterial peritonitis. J Clin Microbiol 48 (2010), 456–459.
[39] Dupont, H., Friggeri, A., Touzeau, J., Airapetian, N., Tinturier, F., Lobjoie, E., et al. Enterococci increase the morbidity and mortality associated with severe intra-abdominal infections in elderly patients hospitalized in the intensive care unit. J Antimicrob Chemother 66 (2011), 2379–2385.
[40] Kaffarnik, M.F., Urban, M., Hopt, U.T., Utzolino, S., Impact of enterococcus on immunocompetent and immunosuppressed patients with perforation of the small or large bowel. Technol Health Care 20 (2012), 37–48.
[41] Cohn, S.M., Lipsett, P.A., Buchman, T.G., Cheadle, W.G., Milsom, J.W., O'Marro, S., et al. Comparison of intravenous/oral ciprofloxacin plus metronidazole versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections. Ann Surg 232 (2000), 254–262.
[42] Malangoni, M.A., Song, J., Herrington, J., Choudhri, S., Pertel, P., Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections. Ann Surg 244 (2006), 204–211.
[43] Solomkin, J., Zhao, Y.P., Ma, E.L., Chen, M.J., Hampel, B., Moxifloxacin is non-inferior to combination therapy with ceftriaxone plus metronidazole in patients with community-origin complicated intra-abdominal infections. Int J Antimicrob Agents 34 (2009), 439–445.
[44] Wacha, H., Warren, B., Bassaris, H., Nikolaidis, P., Comparison of sequential intravenous/oral ciprofloxacin plus metronidazole with intravenous ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections. Surg Infect 7 (2006), 341–354.
[45] Babinchak, T., Ellis-Grosse, E., Dartois, N., Rose, G.M., Loh, E., The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data. Clin Infect Dis 41:Suppl. 5 (2005), S354–S367.
[46] Chen, Z., Wu, J., Zhang, Y., Wei, J., Leng, X., Bi, J., et al. Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial. BMC Infect Dis, 10, 2010, 217.
[47] Qvist, N., Warren, B., Leister-Tebbe, H., Zito, E.T., Pedersen, R., McGovern, P.C., et al. Efficacy of tigecycline versus ceftriaxone plus metronidazole for the treatment of complicated intra-abdominal infections: results from a randomized, controlled trial. Surg Infect 13 (2012), 102–109.
[48] Towfigh, S., Pasternak, J., Poirier, A., Leister, H., Babinchak, T., A multicentre, open-label, randomized comparative study of tigecycline versus ceftriaxone sodium plus metronidazole for the treatment of hospitalized subjects with complicated intra-abdominal infections. Clin Microbiol Infect 16 (2010), 1274–1281.
[49] Paul, M., Shani, V., Muchtar, E., Kariv, G., Robenshtok, E., Leibovici, L., Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother 54 (2010), 4851–4863.
[50] Cattan, P., Yin, D.D., Sarfati, E., Lyu, R., De Zelicourt, M., Fagnani, F., Cost of care for inpatients with community-acquired intra-abdominal infections. Eur J Clin Microbiol Infect Dis 21 (2002), 787–793.
[51] Mosdell, D.M., Morris, D.M., Voltura, A., Pitcher, D.E., Twiest, M.W., Milne, R.L., et al. Antibiotic treatment for surgical peritonitis. Ann Surg 214 (1991), 543–549.
[52] Edelsberg, J., Berger, A., Schell, S., Mallick, R., Kuznik, A., Oster, G., Economic consequences of failure of initial antibiotic therapy in hospitalized adults with complicated intra-abdominal infections. Surg Infect 9 (2008), 335–347.
[53] Dupont, H., Carbon, C., Carlet, J., Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial. The Severe Generalized Peritonitis Study Group. Antimicrob Agents Chemother 44 (2000), 2028–2033.
[54] Montravers, P., Mira, J.P., Gangneux, J.P., Leroy, O., Lortholary, O., A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units. Clin Microb Infect 17 (2011), 1061–1067.
[55] De Waele, J.J., Ravyts, M., Depuydt, P., Blot, S.I., Decruyenaere, J., Vogelaers, D., De-escalation after empirical meropenem treatment in the intensive care unit: fiction or reality?. J Crit Care 25 (2010), 641–646.
[56] Heenen, S., Jacobs, F., Vincent, J.L., Antibiotic strategies in severe nosocomial sepsis: why do we not de-escalate more often?. Crit Care Med 40 (2012), 1404–1409.
[57] Morel, J., Casoetto, J., Jospe, R., Aubert, G., Terrana, R., Dumont, A., et al. De-escalation as part of a global strategy of empiric antibiotherapy management. A retrospective study in a medico-surgical intensive care unit. Crit Care, 14, 2010, R225.
[58] Schein, M., Assalia, A., Bachus, H., Minimal antibiotic therapy after emergency abdominal surgery: a prospective study. Br J Surg 81 (1994), 989–991.
[59] Basoli, A., Chirletti, P., Cirino, E., D'Ovidio, N.G., Doglietto, G.B., Giglio, D., et al. A prospective, double-blind, multicenter, randomized trial comparing ertapenem 3 vs. ≥ 5 days in community-acquired intraabdominal infection. J Gastrointest Surg 12 (2008), 592–600.
[60] Société française d'anesthésie et de réanimation, Prise en charge des péritonites communautaires. Ann Fr Anesth Reanim 20:Suppl 2 (2000), 350s–367s.
[61] Solomkin, J.S., Mazuski, J.E., Bradley, J.S., Rodvold, K.A., Goldstein, E.J., Baron, E.J., et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 50 (2010), 133–164.
[62] Beltran, M.A., Almonacid, J., Vicencio, A., Gutierrez, J., Cruces, K.S., Cumsille, M.A., Predictive value of white blood cell count and C-reactive protein in children with appendicitis. J Pediatr Surg 42 (2007), 1208–1214.
[63] Kwan, K.Y., Nager, A.L., Diagnosing pediatric appendicitis: usefulness of laboratory markers. Am J Amerg Med 28 (2010), 1009–1015.
[64] Dumont, R., Cinotti, R., Lejus, C., Caillon, J., Boutoille, D., Roquilly, A., et al. The microbiology of community-acquired peritonitis in children. Pediatr Infect Dis J 30 (2011), 131–135.
[65] Guillet-Caruba, C., Cheikhelard, A., Guillet, M., Bille, E., Descamps, P., Yin, L., et al. Bacteriologic epidemiology and empirical treatment of pediatric complicated appendicitis. Diagn Microbiol Infect Dis 69 (2011), 376–381.
[66] Lin, W.J., Lo, W.T., Chu, C.C., Chu, M.L., Wang, C.C., Bacteriology and antibiotic susceptibility of community-acquired intra-abdominal infection in children. J Microbiol Immunol Infect 39 (2006), 249–254.
[67] Rice, H.E., Brown, R.L., Gollin, G., Caty, M.G., Gilbert, J., Skinner, M.A., et al. Results of a pilot trial comparing prolonged intravenous antibiotics with sequential intravenous/oral antibiotics for children with perforated appendicitis. Arch Surg 136 (2001), 1391–1395.
[68] Schmitt, F., Clermidi, P., Dorsi, M., Cocquerelle, V., Gomes, C.F., Becmeur, F., Bacterial studies of complicated appendicitis over a 20-year period and their impact on empirical antibiotic treatment. J Pediatr Surg 47 (2012), 2055–2062.
[69] Feigin, R.D., Cherry, J., Demmler, G., Kaplan, S., Textbook of pediatric infectious diseases. 2004, Saunders.
[70] van Ruler, O., Kiewiet, J.J., Boer, K.R., Lamme, B., Gouma, D.J., Boermeester, M.A., et al. Failure of available scoring systems to predict ongoing infection in patients with abdominal sepsis after their initial emergency laparotomy. BMC Surg, 11, 2011, 38.
[71] Paugam-Burtz, C., Dupont, H., Marmuse, J.P., Chosidow, D., Malek, L., Desmonts, J.M., et al. Daily organ-system failure for diagnosis of persistent intra-abdominal sepsis after postoperative peritonitis. Intensive Care Med 28 (2002), 594–598.
[72] Koperna, T., Schulz, F., Relaparotomy in peritonitis: prognosis and treatment of patients with persisting intraabdominal infection. World J Surg 24 (2000), 32–37.
[73] Hutchins, R.R., Gunning, M.P., Lucas, D.N., Allen-Mersh, T.G., Soni, N.C., Relaparotomy for suspected intraperitoneal sepsis after abdominal surgery. World J Surg 28 (2004), 137–141.
[74] Ayerza, H.A., Abcès abdominaux. À propos de 530 cas. Chirurgie 120 (1994), 551–555 [discussion 554–5].
[75] McLean, T.R., Simmons, K., Svensson, L.G., Management of postoperative intra-abdominal abscesses by routine percutaneous drainage. Surg Gynecol Obstet 176 (1993), 167–171.
[76] Benoist, S., Panis, Y., Pannegeon, V., Soyer, P., Watrin, T., Boudiaf, M., et al. Can failure of percutaneous drainage of postoperative abdominal abscesses be predicted?. Am J Surg 184 (2002), 148–153.
[77] Brivet, F.G., Smadja, C., Hilbert, U., Vons, C., Jacobs, F., Gordji-Therani, H., et al. Usefulness of abdominal CT scan in severe peritoneal sepsis linked to primary peritonitis. Scand J Infect Dis 37 (2005), 76–78.
[78] Crema, M.D., Richarme, D., Azizi, L., Hoeffel, C.C., Tubiana, J.M., Arrive, L., Pouchography, CT, and MRI features of ileal J pouch-anal anastomosis. AJR Am J Roentgenol 187 (2006), W594–W603.
[79] van Randen, A., Lameris, W., van Es, H.W., van Heesewijk, H.P., van Ramshorst, B., Ten Hove, W., et al. A comparison of the accuracy of ultrasound and computed tomography in common diagnoses causing acute abdominal pain. Eur Radiol 21 (2011), 1535–1545.
[80] Bader, F.G., Schroder, M., Kujath, P., Muhl, E., Bruch, H.P., Eckmann, C., Diffuse postoperative peritonitis: value of diagnostic parameters and impact of early indication for relaparotomy. Eur J Med Res 14 (2009), 491–496.
[81] Werner, P., Faivre, E., Langonnet, F., Belghiti, J., La tomodensitométrie et le drainage percutanée modifient les indications de réintervention après chirurgie digestive. Ann Fr Anesth Reanim 9 (1990), 261–264.
[82] Determann, R.M., van Till, J.W., van Ruler, O., van Veen, S.Q., Schultz, M.J., Boermeester, M.A., sTREM-1 is a potential useful biomarker for exclusion of ongoing infection in patients with secondary peritonitis. Cytokine 46 (2009), 36–42.
[83] Mulari, K., Leppaniemi, A., Severe secondary peritonitis following gastrointestinal tract perforation. Scand J Surg 93 (2004), 204–208.
[84] Novotny, A.R., Emmanuel, K., Hueser, N., Knebel, C., Kriner, M., Ulm, K., et al. Procalcitonin ratio indicates successful surgical treatment of abdominal sepsis. Surgery 145 (2009), 20–26.
[85] Rau, B.M., Frigerio, I., Buchler, M.W., Wegscheider, K., Bassi, C., Puolakkainen, P.A., et al. Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis: a prospective, international multicenter study. Arch Surg 142 (2007), 134–142.
[86] Schneider, C.P., Seyboth, C., Vilsmaier, M., Kuchenhoff, H., Hofner, B., Jauch, K.W., et al. Prognostic factors in critically ill patients suffering from secondary peritonitis: a retrospective, observational, survival time analysis. World J Surg 33 (2009), 34–43.
[87] Paugam-Burtz, C., Mantz, J., Dupont, H., Dehoux, M., Procalcitonin levels and sequential organ failure assessment scores in secondary peritonitis. Arch Surg, 142, 2007, 803 [author reply 803–4].
[88] Montravers, P., Gauzit, R., Muller, C., Marmuse, J.P., Fichelle, A., Desmonts, J.M., Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin Infect Dis 23 (1996), 486–494.
[89] Roehrborn, A., Thomas, L., Potreck, O., Ebener, C., Ohmann, C., Goretzki, P.E., et al. The microbiology of postoperative peritonitis. Clin Infect Dis 33 (2001), 1513–1519.
[90] Seguin, P., Fedun, Y., Laviolle, B., Nesseler, N., Donnio, P.Y., Malledant, Y., Risk factors for multidrug-resistant bacteria in patients with postoperative peritonitis requiring intensive care. J Antimicrob Chemother 65 (2010), 342–346.
[91] Augustin, P., Kermarrec, N., Muller-Serieys, C., Lasocki, S., Chosidow, D., Marmuse, J.P., et al. Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis. Crit Care, 14, 2010, R20.
[92] Swenson, B.R., Metzger, R., Hedrick, T.L., McElearney, S.T., Evans, H.L., Smith, R.L., et al. Choosing antibiotics for intra-abdominal infections: what do we mean by “high-risk”?. Surg Infect 10 (2009), 29–39.
[93] Kumar, A., Roberts, D., Wood, K.E., Light, B., Parrillo, J.E., Sharma, S., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34 (2006), 1589–1596.
[94] Dupont, H., Vael, C., Muller-Serieys, C., Chosidow, D., Mantz, J., Marmuse, J.P., et al. Prospective evaluation of virulence factors of enterococci isolated from patients with peritonitis: impact on outcome. Diagn Microbiol Infect Dis 60 (2008), 247–253.
[95] Seguin, P., Brianchon, C., Launey, Y., Laviolle, B., Nesseler, N., Donnio, P.Y., et al. Are enterococci playing a role in postoperative peritonitis in critically ill patients?. Eur J Clin Microbiol Infect Dis 31 (2012), 1479–1485.
[96] Sitges-Serra, A., Lopez, M.J., Girvent, M., Almirall, S., Sancho, J.J., Postoperative enterococcal infection after treatment of complicated intra-abdominal sepsis. Br J Surg 89 (2002), 361–367.